Nasdaq Stocks

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Macy's Inc (Symbol: M), where a total volume of 79,633 contracts has been traded thus far today, a contract volume which is representative of approximately 8.0

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Ulta Beauty Inc (Symbol: ULTA), where a total volume of 9,081 contracts has been traded thus far today, a contract volume which is representative of approximat

In afternoon trading on Friday, Utilities stocks are the worst performing sector, not showing much of a gain. Within that group, Public Service Enterprise Group Inc (Symbol: PEG) and Entergy Corp (Symbol: ETR) are two of the day's laggards, showing a loss of 4.3% and 4.1%, re

The best performing sector as of midday Friday is the Financial sector, higher by 5.0%. Within that group, The Charles Schwab Corporation (Symbol: SCHW) and Etrade Financial Corporation (Symbol: ETFC) are two large stocks leading the way, showing a gain of 13.7% and 13.4%, re

Panic selling sent the market crashing yesterday, as the coronavirus continued to spread globally, having been declared a pandemic. Both the Dow and the S&P 500 appeared to be in free-fall, down nearly 10% for the day. The Nasdaq dropped more than 9 points.

In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view

A particularly strong insider buying signal is what we call a "cluster-buy" where three or more different insiders make open market purchases within a short period of one another. At Cincinnati Financial Corp. (Symbol: CINF), 3 different insiders purchased 4,023 shares at an

In trading on Friday, shares of Canadian Utilities Ltd's Cumulative Redeemable Second Preferred Shares Series CC (TSX: CU-PRF.TO) were yielding above the 5.5% mark based on its quarterly dividend (annualized to $1.125), with shares changing hands as low as $20.03 on the day.

Lyft (LYFT) has lost 55% since its Q4 earnings on February 11th. The initial drop-off was an over-exaggeration by the markets, and the coronavirus continues to pull these shares down to their lowest levels since the stock went public last year. I think LYFT has been unjustly sol

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

Early gains in the three major U.S. stock-market indexes shrank, but markets remained in positive territory.

The delayed actions for the Dow Jones Industrial Average and the S&P 500, along with other indexes managed by the company, include the majority of weight updates and membership changes.

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.

Inovio Pharmaceuticals, Inc.’s INO adjusted loss of 32 cents per share in fourth-quarter 2019 was wider than the Zacks Consensus Estimate of a loss of 23 cents.

Inovio Pharmaceuticals, Inc.’s INO adjusted loss of 32 cents per share in fourth-quarter 2019 was wider than the Zacks Consensus Estimate of a loss of 23 cents.